Functional epidermal growth factor gene polymorphisms and risk of gastric cancer

Oncology Letters

Volumn 5, Issue 2, 2013, Pages 631-636

  Zhan, Zhen ^a   Chen, Yajun ^b   Wu, Juan ^a   Zhang, Junfeng ^a   Tong, Shujuan ^a   Zhang, Chunbing ^b   Yang, Yaping ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Chinese population; Epidermal growth factor polymorphisms; Gastric cancer; Molecular epidemiology

Indexed keywords

EPIDERMAL GROWTH FACTOR; ISOLEUCINE; METHIONINE;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH CANCER;

EID: 84871558669     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1041     Document Type: Article

References (19)

1. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999.
2. Crew KD and Neugut AI: Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31: 450-464, 2004.
3. Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
4. Lu SH, Hsieh LL, Luo FC and Weinstein IB: Amplification of the EGF receptor and c-myc genes in human esophageal cancer. Int J Cancer 42: 502-505, 1988.
5. Stoscheck CM and King LE: Role of epidermal growth factor in carcinogenesis. Cancer Research 46:1030-1037, 1986.
6. Yasui W, Hata J, Yokozaki H, et al: Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 41: 211-217, 1988.
7. Tokunaga A, Onda M, Okuda T, et al: Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer 75: 1418-1425, 1995.
8. Fenton SE, Groce NS and Lee DC: Characterization of the mouse epidermal growth factor promoter and 5'-flanking region. Role for an atypical TATA sequence. J Biol Chem 271: 30870-30878, 1996.
9. Mullhaupt B, Feren A, Jones A and Fodor E: DNA sequence and functional characterization of the human and rat epidermal growth factor promoter: regulation by cell growth. Gene 50: 191-200, 2000.
10. Zhu J, Meng X, Yan F, et al: A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population. J Hum Genet 55: 236-240, 2010.
11. Chen K, Wei Y, Yang H and Li B: Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Genet Test Mol Biomarkers 15: 251-255, 2011.
12. Amend KL, Elder JT, Tomsho LP, et al: EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 64: 2668-2672, 2004.
13. Hamai Y, Matsumura S, Matsusaki K, et al: A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 72: 133-138, 2005.
14. Goto Y, Ando T, Goto H and Hamajima N: No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol Biomarkers Prev 14: 2454-2456, 2005.
15. Shen H, Xu Y, Qian Y, et al: Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88: 601-606, 2000.
16. Shen H, Xu Y, Zheng Y, et al: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 95: 332-336, 2001.
17. Shahbazi M, Pravica V, Nasreen N, et al: Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359: 397-401, 2002.
18. McCarron SL, Bateman AC, Theaker JM and Howell WM: EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 107: 673-675, 2003.
19. Randerson-Moor JA, Gaut R, Turner F, et al: The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol 123: 755-759, 2004.